Zheng Quan Zhi Xing·2025-06-26 16:39Core Viewpoint - The legal opinion confirms that the procedures for convening and holding the annual general meeting of Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co., Ltd. comply with relevant Chinese laws and regulations as well as the company's articles of association [2][3][7] Group 1: Meeting Procedures - The notice for the annual general meeting was published on April 29, 2025, on the Shanghai Stock Exchange website and other media, meeting the 21-day notice requirement [3][4] - The meeting utilized a combination of on-site and online voting, with specific time slots for online voting on June 26, 2025 [4][6] Group 2: Voting Participation - A total of 11 shareholders participated in the on-site voting, representing 316,414,103 shares, which is 30.5250% of the total voting shares [5] - The combined results showed that 190 shareholders participated, representing 409,978,047 shares, or 39.5513% of the total voting shares [5][6] Group 3: Voting Results - The meeting passed several resolutions, including the annual reports and financial statements, with the majority of votes in favor [6][7] - The special resolution regarding the authorization for the board to issue shares was approved with more than two-thirds of the votes [7]